We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.03%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$33.1B
AUM Growth
+$1.62B
(+5.1%)
Cap. Flow
+$885M
Cap. Flow
% of AUM
2.67%
Top 10 Holdings %
Top 10 Hldgs %
37%
Holding
1,568
New
69
Increased
691
Reduced
367
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$864M |
| 2 |
Bank of America
BAC
|
+$84.7M |
| 3 |
Edwards Lifesciences
EW
|
+$69M |
| 4 |
Alibaba
BABA
|
+$65.5M |
| 5 |
Advanced Micro Devices
AMD
|
+$56.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$83.9M |
| 2 |
Tyler Technologies
TYL
|
+$73.9M |
| 3 |
Core & Main
CNM
|
+$73M |
| 4 |
Itron
ITRI
|
+$71.3M |
| 5 |
Uber
UBER
|
+$70.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.91% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 12.06% |
| 4 | Communication Services | 11.11% |
| 5 | Consumer Discretionary | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Neurocrine Biosciences
NBIX
$15.9B
| $28.5M | 0.09% |
200,867
+91,400
| +83% | +$13.2M |
|
202
CBIZ
CBZ
$2.96B
| $28.4M | 0.09% |
562,000
-185,000
| -25% | -$9.73M |
|
203
Simon Property Group
SPG
$71.4B
| $28.3M | 0.09% |
152,698
+3,716
| +2% | +$675K |
|
204
Coca-Cola Europacific Partners
CCEP
$47.3B
| $28.3M | 0.09% |
311,523
+75,990
| +32% | +$6.86M |
|
205
NetApp
NTAP
$39.6B
| $28.1M | 0.09% |
262,732
+135,715
| +107% | +$15.5M |
|
|
HIMX
206
Himax Technologies
HIMX
$2.63B
| $28.1M | 0.08% |
3,429,263
+1,676,831
| +96% | +$14.2M |
|
207
Moody's
MCO
$82.8B
| $27.8M | 0.08% |
54,456
+350
| +0.6% | +$171K |
|
208
Deckers Outdoor
DECK
$12.4B
| $27.3M | 0.08% |
263,664
-67,000
| -20% | -$6.28M |
|
209
Cognex
CGNX
$10.2B
| $27.3M | 0.08% |
758,831
+328,427
| +76% | +$13.3M |
|
210
Cellebrite
CLBT
$3.8B
| $27.2M | 0.08% |
1,510,000
-1,390,000
| -48% | -$25M |
|
211
Fastenal
FAST
$59.9B
| $27M | 0.08% |
673,438
-23,185
| -3% | -$976K |
|
212
Corteva
CTVA
$50.4B
| $27M | 0.08% |
402,845
+28,517
| +8% | +$1.84M |
|
213
Digital Realty Trust
DLR
$72.9B
| $26.8M | 0.08% |
173,487
+12,215
| +8% | +$2.01M |
|
214
Kadant
KAI
$3.94B
| $26.5M | 0.08% |
93,079
-2,000
| -2% | -$568K |
|
215
Realty Income
O
$59.2B
| $26.2M | 0.08% |
464,780
-39,666
| -8% | -$2.3M |
|
216
Republic Services
RSG
$65.6B
| $26.1M | 0.08% |
123,086
-5,145
| -4% | -$1.11M |
|
217
Krystal Biotech
KRYS
$9.85B
| $26.1M | 0.08% |
105,800
+39,000
| +58% | +$8.21M |
|
218
Veeva Systems
VEEV
$39.2B
| $25.8M | 0.08% |
115,681
-6,672
| -5% | -$1.77M |
|
219
eBay
EBAY
$45.5B
| $25.8M | 0.08% |
295,742
-5,372
| -2% | -$465K |
|
220
Roblox
RBLX
$25.4B
| $25.7M | 0.08% |
317,111
+116,899
| +58% | +$12.4M |
|
221
Zoetis
ZTS
$30.4B
| $25.7M | 0.08% |
204,213
+5,806
| +3% | +$757K |
|
222
Becton Dickinson
BDX
$50B
| $25.5M | 0.08% |
131,391
+2
| +0% | +$381 |
|
223
Elevance Health
ELV
$86.6B
| $25.5M | 0.08% |
72,637
-1,799
| -2% | -$608K |
|
224
MKS Inc
MKSI
$20.7B
| $25.3M | 0.08% |
158,400
+48,800
| +45% | +$7.24M |
|
225
Symbotic
SYM
$5.35B
| $25.2M | 0.08% |
423,020
+148,842
| +54% | +$9.83M |
|
Similar funds
VIA
Handelsbanken Fonder's Q4 2025 Portfolio in Review
As of Q4 2025, Handelsbanken Fonder held 1,568 positions worth $33.1B, up 5.1% from $31.5B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Handelsbanken Fonder's Q4 2025 filing shows 69 new, 691 increased, 367 reduced and 73 closed positions. Its largest new stake was Fluence Energy: 857,654 shares worth $17M. The largest sale was Eli Lilly, an estimated $83.9M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 39% a quarter earlier, followed by Healthcare and Financials.
- Handelsbanken Fonder's largest Q4 2025 buy was Fluence Energy: 857,654 shares worth $17M.
- Handelsbanken Fonder added most to Amazon in Q4 2025, an estimated $864M increase.
- Handelsbanken Fonder's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $83.9M.
- Handelsbanken Fonder fully exited Kellanova in Q4 2025, selling an estimated $26M.
- Handelsbanken Fonder's ten largest holdings make up 37% of its $33.1B portfolio in Q4 2025.
- Handelsbanken Fonder opened 69 new positions and closed 73 in Q4 2025.
- Handelsbanken Fonder's portfolio value rose 5.1% quarter-over-quarter to $33.1B.
Based on Handelsbanken Fonder's 13F filing for Q4 2025, filed 6 Feb 2026.